2-(2-Methylpropyl)-4-quinolinecarboxamide(29197-43-1)
- Name: 2-(2-Methylpropyl)-4-quinolinecarboxamide
- Synonyms:2-(2-methylpropyl)-4-quinolinecarboxamide;29197-43-1;2-(2-methylpropyl)quinoline-4-carboxamide;DTXSID20696848;A819804
- Molecular Formula:C14H16N2O
- Molecular Weight:228.29
- CAS Registry Number:29197-43-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.29197-43-1 2-(2-methylpropyl)-4-quinolinecarboxamide
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 490034-86-1/(3S)-3-amino-3-[3-(trifluoromethyl)phenyl]propanoic acid hydrochloride
- 1160263-13-7/6-Chloro-2-(2,4-dimethylphenyl)quinoline-4-carbonyl chloride
- 1241675-81-9/5-chloro-2-[(2R,6S)-2,6-dimethyl-1,4-oxazinan-4-yl]benzenecarbaldehyde
- 1399715-48-0/Setafrastat
- 75575-50-7/Lithium salicylate monohydrate
- 1964503-40-9/Propargyl-PEG1-SS-PEG1-Propargyl
- 2006277-00-3/Methyl 4-[4-(Trifluoromethoxy)phenyl]pyrimidine-2-carboxylate
- 1382847-91-7/Methyl 5-bromo-4-methylpyridine-3-carboxylate
- 1040690-10-5/4-(Heptyloxy)-N-[2-(phenethyloxy)benzyl]aniline
- 1491917-83-9/Sacituzumab govitecan
- 1638768-01-0/Methyl 3-(((tert-butoxycarbonyl)amino)methyl)bicyclo[1.1.1]pentane-1-carboxylate
- 1185298-56-9/4-(tert-Butyl)phenyl 3-pyrrolidinylmethyl ether hydrochloride
- 13292-48-3/[(9E,19E)-26-[(E)-[2-(dimethylamino)ethyl-methylhydrazinylidene]methyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
- 749269-77-0/Cyclopropanecarboxylic acid, 1-(2-fluoro-4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)-
- 944730-39-6/Cuprate(4-), [[3,3',3'',3'''-[(29H,31H-phthalocyanine-1,8,15,22-tetrayl-kappaN29,kappaN30,kappaN31,kappaN32)tetrakis(sulfonyl)]tetrakis[1-propanesulfonato]](6-)]-, sodium (1:4), (SP-4-1)-
- 356539-51-0/3-Chloro-N-(cyclopropylmethyl)-2-methylaniline
- 1289388-16-4/tert-Butyl 3-(((1-(pyrazin-2-yl)ethyl)amino)methyl)piperidine-1-carboxylate
- 5411-21-2/2-(7,8-Dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2h)-yl)ethyl propanoate
- 159002-28-5/2-Ethoxy-9-(5-O-phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine
- 29197-43-1/2-(2-Methylpropyl)-4-quinolinecarboxamide
- 1334714-66-7/Eravacycline dihydrochloride
- 152718-74-6/Trimethylsilyl 2,3,3,3-tetrafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)propanoate
- 1019111-23-9/[2-(3,5-Dimethyl-[1,2,4]triazol-4-yl)-phenoxy]-acetic acid
- 1132746-04-3/4-(2-{Propyl[(~2~H_7_)propyl]amino}ethyl)-1,3-dihydro-2H-indol-2-one
- 931107-55-0/2,2-Dimethyl-N~1~,N~3~-bis[(1R)-1-phenylethyl]propane-1,3-diamine
- 1499193-54-2/CID 156594291
- 1255502-07-8/Lithium (R)-3,5-dihydroxy-3-methylpentanoate
- 1286274-16-5/tert-Butyl (1R*,4R*)-4-(pentan-3-ylamino)cyclohexylcarbamate
- 1407997-83-4/(2R)-1-Boc-2-methyl-2-(methylaminomethyl)-pyrrolidine
- 946699-16-7/3-Fluoro-4-(2-isopropyl-5-methylphenoxy)aniline